+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 1Hour
All Genders
Healthy Volunteers
ID00747851

Study of Inflammatory Responses in Premature and Healthy Newborns to Understand Necrotizing Enterocolitis

Led by University of Utah · Updated on 2025-12-05

388

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how certain immune cells called polymorphonuclear leukocytes PMNs from premature infants at risk for necrotizing enterocolitis NEC respond to a molecule called platelet-activating factor PAF. NEC is a serious disease affecting about 10% of very low birth weight premature infants, often leading to severe complications or death. This observational study also compares protein synthesis and inflammatory responses in PMNs from premature and healthy term infants, and relates findings to previous data from adults. The study collects cord blood samples from premature infants weighing between 501 and 1500 grams and from healthy term infants shortly after birth. PMNs are isolated and stimulated with PAF to examine protein production, including inflammatory modulators like Interleukin 6 Receptor alpha and Retinoic Acid Receptor alpha. The activity of a protein control pathway called mTOR is also studied in these cells. Researchers follow the premature infants clinically over two years to identify which develop NEC and investigate associated risk factors. Participants are hospitalized newborns in the neonatal intensive care unit NICU meeting weight or gestational age criteria, along with healthy term infants. Cord blood is collected within the first hour of life. Clinical data and multiple health outcomes are tracked for two years, focusing on NEC incidence and survival as the main outcome. The study also gathers information on other medical conditions and protein analyses related to NEC. Safety and long-term monitoring occur through this observation period lasting up to two years.

CONDITIONS

Brief Title

NETs: Protection or Harm in Neonatal Inflammation or Infection

Research Team

C

Christian C Yost, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here